Lysosomal storage disorders

[1]  J. Fletcher.  Screening for lysosomal storage disorders—A clinical perspective , 2006, Journal of Inherited Metabolic Disease.

[2]  M. Beck.  Variable clinical presentation in lysosomal storage disorders , 2001, Journal of Inherited Metabolic Disease.

[3]  S. Michel,et al.  Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease , 1992, Human Genetics.

[4]  F. Sheth,et al.  Prenatal diagnosis of tay-sachs b1 variant in a maharashtrian family. , 2002, Indian pediatrics.

[5]  F. Sheth,et al.  Morquio-B syndrome (MPS-IV B) associated with β-galactosidase deficiency in two siblings , 2002, Indian journal of pediatrics.

[6]  R. Giugliani,et al.  Characterization of beta-galactosidase in leukocytes and fibroblasts of GM1 gangliosidosis heterozygotes compared to normal subjects. , 2000, Clinical biochemistry.

[7]  D. Applegarth,et al.  Incidence of Inborn Errors of Metabolism in British Columbia, 1969–1996 , 2000, Pediatrics.

[8]  T. Cox,et al.  Metachromatic leucodystrophy: a newly identified mutation in arylsulphatase A, D281Y, found as a compound heterozygote with I179L in an adult onset case , 1999, Human mutation.

[9]  A. Harris,et al.  Frequency of arylsulphatase A pseudodeficiency associated mutations in a healthy population. , 1994, Journal of medical genetics.

[10]  I. Verma,et al.  Sphingomyelinase enzyme assay in Niemann-Pick disease , 1993, Indian journal of pediatrics.

[11]  R. Brady,et al.  Lysosomal Storage Diseases , 1986, The Lancet.

[12]  S. Kornfeld,et al.  Lysosomal storage defects. , 1985, Hospital practice.

[13]  J. O'brien,et al.  Tay-sachs disease. Detection of heterozygotes and homozygotes by serum hexosaminidase assay. , 1970, The New England journal of medicine.